Table 2 Reduced antitumor responses in... | American Society of Hematology

Table 2

Reduced antitumor responses in recipients of GKO allo-HCT

Experiment	Treatment		N	Death (n)	Tumor at autopsy, n*	Paralysis, n†	Tumor-free, n‡
Experiment	P815	Allo-HCT	N	Death (n)	Tumor at autopsy, n*	Paralysis, n†	Tumor-free, n‡
A	Day 0 (10⁴)	WT	11	1	1	0	10
		GKO	12	10	10	0	2
		None	7	7	7	0	0
B	Day 0 (2 × 10⁴)	WT	9	6	0	6	3
		GKO	9	9	9	1	0
		None	7	7	7	0	0
C	Day −2 (2 × 10⁴)	WT	8	6	2	5	2
		GKO	9	9	9	4	0
		None	7	7	7	1	0

Experiment	Treatment		N	Death (n)	Tumor at autopsy, n*	Paralysis, n†	Tumor-free, n‡
Experiment	P815	Allo-HCT	N	Death (n)	Tumor at autopsy, n*	Paralysis, n†	Tumor-free, n‡
A	Day 0 (10⁴)	WT	11	1	1	0	10
		GKO	12	10	10	0	2
		None	7	7	7	0	0
B	Day 0 (2 × 10⁴)	WT	9	6	0	6	3
		GKO	9	9	9	1	0
		None	7	7	7	0	0
C	Day −2 (2 × 10⁴)	WT	8	6	2	5	2
		GKO	9	9	9	4	0
		None	7	7	7	1	0

Number of mice with tumor at autopsy.

Number of mice that were killed because of the development of hind limb paralysis.

Number of long-term surviving mice without tumor or paralysis.